Cleared Traditional

K812334 - B-NEOCEPT

K812334 is an FDA 510(k) clearance for B-NEOCEPT, manufactured by Organon, Inc.. The device is a Class 2 Chemistry device with product code JHJ cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K812334 · Organon, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1981
Decision
14d
Days
Class 2
Risk

K812334 is an FDA 510(k) clearance for the B-NEOCEPT. Classified as Agglutination Method, Human Chorionic Gonadotropin (product code JHJ), Class II - Special Controls.

Submitted by Organon, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 1, 1981 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Organon, Inc. devices

FDA 510(k) Submission Details - K812334

510(k) Number K812334 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 1981
Decision Date September 01, 1981
Days to Decision 14 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 88d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JHJ Device Classification - Class 2, Special Controls

Product Code JHJ Agglutination Method, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JHJ Agglutination Method, Human Chorionic Gonadotropin

All 54
Devices cleared under the same product code (JHJ) and FDA review panel - the closest regulatory comparables to K812334.
PREG/TEX PREGNANCY TEST
K821387 · Texas Immunology, Inc. · Jun 1982
ACCURATE BETA
K812967 · Organon, Inc. · Nov 1981
ANSWER (R)
K812924 · Armkel, LLC · Nov 1981
ACCURATE I
K812261 · Organon, Inc. · Aug 1981
OREIA II, B-HCG
K811940 · Organon, Inc. · Aug 1981
NEOCEPT
K811941 · Organon, Inc. · Jul 1981